Nucleus Basalis Meynert Cholinergic Neurons

Nucleus Basalis Meynert Cholinergic Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Nucleus Basalis of Meynert Cholinergic Neurons</th>
</tr>
<tr>
<td class="infobox-header" colspan="2">Basal Forebrain Cholinergic System</td>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td><a href="https://portal.brain-map.org/atlases-and-data/rnaseq" target="_blank">Mouse: GSN0002005</a></td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > GABAergic > Basal Forebrain Cholinergic</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>ChAT, p75NTR (NGFR), SLC18A3 (VAChT), NGF, BDNF</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Substantia innominata, Horizontal Diagonal Band, Vertical Diagonal Band</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Dementia with Lewy Bodies](/diseases/dementia-lewy-bodies), [Parkinson's Disease](/diseases/parkinsons-disease)</td>
</tr>
</table>

Nucleus Basalis of Meynert Cholinergic Neurons

Introduction

Nucleus Basalis Meynert Cholinergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Nucleus Basalis Meynert Cholinergic Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Nucleus Basalis of Meynert Cholinergic Neurons</th>
</tr>
<tr>
<td class="infobox-header" colspan="2">Basal Forebrain Cholinergic System</td>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td><a href="https://portal.brain-map.org/atlases-and-data/rnaseq" target="_blank">Mouse: GSN0002005</a></td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > GABAergic > Basal Forebrain Cholinergic</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>ChAT, p75NTR (NGFR), SLC18A3 (VAChT), NGF, BDNF</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Substantia innominata, Horizontal Diagonal Band, Vertical Diagonal Band</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Dementia with Lewy Bodies](/diseases/dementia-lewy-bodies), [Parkinson's Disease](/diseases/parkinsons-disease)</td>
</tr>
</table>

Nucleus Basalis of Meynert Cholinergic Neurons

Introduction

Nucleus Basalis Meynert Cholinergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The Nucleus Basalis of Meynert (NBM) is the largest cholinergic nuclei in the basal forebrain and serves as the primary source of cortical acetylcholine. These projection neurons are essential for cortical activation, attention, learning, and memory consolidation [@cholinergic2020][@basal2020]. The NBM is severely affected in Alzheimer's disease (AD), where degeneration of these cholinergic neurons underlies the characteristic cognitive decline and represents a key therapeutic target for symptomatic treatment [@nbm2019][@cholinergic2018].

The NBM is part of the basal forebrain cholinergic system (BFCS), which includes the medial septum (MS), vertical and horizontal diagonal bands of Broca (VDB/HDB), and the nucleus basalis of Meynert proper. Together, these nuclei provide the majority of cholinergic innervation to the hippocampus and neocortex [@basal2017].
<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108) | cholinergic neuron |

Morphology & Electrophysiology

• Morphology: cholinergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108) | cholinergic neuron | Medium |
| Cell Ontology | [CL:2000056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056) | Meynert cell | Medium |

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Neuroanatomy

Location and Organization

The NBM is located in the substantia innominata of the basal forebrain:

• Anterior-Posterior Extent: Spans from the olfactory tubercle to the level of the anterior commissure [@neuroanatomy2016].
• Cell Clusters: Organized into discrete clusters (Ch1-Ch4) with distinct cortical projection patterns [@chch2015].
• Neurovascular Relationships: Adjacent to the anterior choroid artery and lenticulostriate vessels [@basal2014].

Afferent Inputs

NBM cholinergic neurons receive inputs from:

Efferent Projections

Cortical projection patterns:

| Target Region | Function | Cholinergic Modulation |
|--------------|----------|----------------------|
| Prefrontal Cortex | Executive function, working memory | Enhances signal-to-noise ratio [@basal2018] |
| Parietal Cortex | Spatial attention, sensory integration | Facilitates perceptual learning [@cholinergic2017] |
| Temporal Cortex | Object recognition, memory | Enables long-term potentiation [@ach2016] |
| Hippocampus | Episodic memory, navigation | Critical for theta oscillations [@cholinergic2015] |

Neurophysiology

Firing Properties

NBM cholinergic neurons exhibit distinctive electrophysiological characteristics:

• Burst Firing: Calcium-dependent bursting in response to salient stimuli [@burst2014].
• Tonic Activity: Low-frequency tonic firing (2-10 Hz) during rest [@tonic2013].
• State-Dependent Modulation: Firing rates increase during REM sleep and wakefulness [@statedependent2012].
• Theta Phase Locking: Burst firing synchronizes with hippocampal theta oscillations [@theta2011].

Cholinergic Signaling

Acetylcholine release mechanisms:

Molecular Profile

Key Marker Genes

| Gene | Protein | Function |
|------|---------|----------|
| CHAT | Choline Acetyltransferase | ACh synthesis enzyme |
| NGFR | p75NTR | NGF receptor (low-affinity) |
| SLC18A3 | VAChT | Vesicular ACh transport |
| BDNF | Brain-Derived Neurotrophic Factor | Neurotrophic support |
| NTRK1 | TrkA | High-affinity NGF receptor |

Transcriptomic Signature

Single-nucleus RNA sequencing has identified NBM-specific transcriptional programs [@singlenucleus2020]:

• Cholinergic Identity: CHAT, SLC18A3, ACHE (acetylcholinesterase)
• Ion Channels: HCN1, HCN2 (pacemaking), Cav1.3 (L-type calcium)
• Neurotrophin Receptors: NTRK1, NTRK2 (TrkA/B), NGFR (p75NTR)
• Transcription Factors: LHX8, GBX2 (development)

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

NBM degeneration is a hallmark of AD neuropathology:

• Cell Loss: 30-90% loss of NBM cholinergic neurons in AD patients [@nbm2019a].
• Neurofibrillary Tangles: Tau pathology invades NBM neurons early [@tau2018].
• Amyloid Deposition: Aβ plaques found in basal forebrain region [@amyloid2017].
• Cortical Denervation: Loss of cholinergic terminals precedes cognitive symptoms [@cortical2016].
• Therapeutic Target: Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) compensate for ACh deficiency [@ache2015].

Dementia with Lewy Bodies (DLB)

NBM involvement in DLB:

• Lewy Body Pathology: α-Synuclein inclusions in NBM neurons [@lewy2014].
• Cholinergic Deficits: Severe cortical ACh reduction, often worse than AD [@cholinergic2013].
• Fluctuation: Cholinergic dysfunction correlates with attentional fluctuations [@fluctuations2012].
• Treatment Response: Cholinesterase inhibitors show significant benefit [@dlb2011].

Parkinson's Disease (PD)

Cholinergic changes in PD:

• Pedunculopontine Nucleus Degeneration: Additional cholinergic loss beyond NBM [@ppn2010].
• Cognitive Decline: NBM dysfunction contributes to PD-MCI and dementia [@pdmci2019].
• Gait Freezing: Cholinergic deficits underlie postural instability and gait dysfunction [@cholinergic2018a].
• REM Sleep Behavior Disorder: NBM involvement in prodromal cholinopathic stage [@rbd2017].

Other Conditions

• Down Syndrome: Early NBM degeneration predicts early-onset AD [@nbm2016].
• Vascular Dementia: White matter lesions disrupt basal forebrain circuits [@vascular2015].
• Mild Cognitive Impairment: NBM atrophy predicts progression to AD [@mci2014].

Therapeutic Implications

Current Treatments

| Drug | Mechanism | Efficacy |
|------|-----------|----------|
| Donepezil | AChE inhibition | Moderate cognitive improvement [@donepezil2013] |
| Rivastigmine | AChE/BuChE inhibition | Benefits cognition and function [@rivastigmine2012] |
| Galantamine | AChE modulation + nAChR agonism | Enhances cholinergic signaling [@galantamine2011] |
| Memantine | NMDA antagonism | Complements cholinergic therapy [@memantine2010] |

Emerging Therapies

Clinical Trials

• NGF Gene Therapy: AAV-NGF (CERE-110) trial for AD (NCT00876863) [@aavngf2014].
• DBH-NGF: Dopa-beta-hydroxylase-NGF fusion proteins (NCT00017940) [@dbhngf2013].
• Mecamylamine: Nicotinic antagonist/agonist for cognitive enhancement [@mecamylamine2012].

Key Publications

External Links

• Allen Cell Type Atlas: [https://portal.brain-map.org/atlases-and-data/rnaseq](https://portal.brain-map.org/atlases-and-data/rnaseq)
• Alzheimer's Association: [https://www.alz.org/](https://www.alz.org/)
• Lewy Body Dementia Association: [https://www.lbda.org/](https://www.lbda.org/)
• [Cell Types Index](/cell-types) [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Basal Forebrain Cholinergic System
• [Cholinergic Neurons](/cell-types/cholinergic-neurons)
• Acetylcholinesterase
• --

Background

The study of Nucleus Basalis Meynert Cholinergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Nucleus Basalis Meynert Cholinergic Neurons discovered through SciDEX knowledge graph analysis: